| Treatment | Tumor Regression | Tumor-free Survival Total | Median Days to 2 Doublings | Growth Delay (T-C)a | Median T/C (%) Day 26 | |||
| Compound | Dose mg/kg | Number of Partial | Number of Complete | Duration Med/Range (Days) | ||||
| Controlb | 0 | 0/10 | 9.4 | |||||
| DOXb | 8 | 0 | 9 | 9/10 | >13 | >3.6 | 0 | |
| DOX | 5.3 | 0 | 10 | 34.3 28 - 48 | 1/10 | 67 | 57.6 | 0 |
| DOX | 3.5 | 2 | 7 | 23.6 1 - 34 | 1/10 | 54 | 45.0 | 10 |
| DOX-Ob | 9.75 | 2 | 4 | 4/10 | >13 | >3.6 | 6 | |
| DOX-O | 6.5 | 2 | 8 | 28.9 11 - 42 | 1/10 | 58.7 | 49.3 | 8 |
| DOX-O | 4.3 | 1 | 3 | 9.3 2 - 25 | 1/10 | 41.2 | 31.8 | 14 |